130 related articles for article (PubMed ID: 9585617)
1. A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2.
Liede A; Rehal P; Vesprini D; Jack E; Abrahamson J; Narod SA
Am J Hum Genet; 1998 Jun; 62(6):1543-4. PubMed ID: 9585617
[No Abstract] [Full Text] [Related]
2. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
[No Abstract] [Full Text] [Related]
3. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Tonin P; Weber B; Offit K; Couch F; Rebbeck TR; Neuhausen S; Godwin AK; Daly M; Wagner-Costalos J; Berman D; Grana G; Fox E; Kane MF; Kolodner RD; Krainer M; Haber DA; Struewing JP; Warner E; Rosen B; Lerman C; Peshkin B; Norton L; Serova O; Foulkes WD; Garber JE
Nat Med; 1996 Nov; 2(11):1179-83. PubMed ID: 8898735
[No Abstract] [Full Text] [Related]
4. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.
Eisinger F; Jacquemier J; Noguès C; Birnbaum D; Sobol H
Cancer; 1999 May; 85(10):2291-5. PubMed ID: 10326710
[No Abstract] [Full Text] [Related]
6. BRCA1/2 germline mutations: a marker for radioresistance or radiosensitivity?
Formenti SC; Preston-Martin S; Haffty BG
J Clin Oncol; 2000 Mar; 18(5):1159-60. PubMed ID: 10694571
[No Abstract] [Full Text] [Related]
7. A family with three germline mutations in BRCA1 and BRCA2.
Liede A; Metcalfe K; Offit K; Brown K; Miller S; Narod SA; Moslehi R
Clin Genet; 1998 Sep; 54(3):215-8. PubMed ID: 9788724
[TBL] [Abstract][Full Text] [Related]
8. Search for TSG101 germ-line mutations in BRCA1/BRCA2-negative breast/ovarian cancer families.
Hofferbert S; Brohm M; Weber BH
Cancer Genet Cytogenet; 1998 Apr; 102(1):86-7. PubMed ID: 9530348
[No Abstract] [Full Text] [Related]
9. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
[TBL] [Abstract][Full Text] [Related]
10. Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers.
Staff S; Nupponen NN; Borg A; Isola JJ; Tanner MM
Genes Chromosomes Cancer; 2000 Aug; 28(4):432-42. PubMed ID: 10862052
[TBL] [Abstract][Full Text] [Related]
11. Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families.
Papp J; Raicevic L; Milasin J; Dimitrijevic B; Radulovic S; Olah E
Oncol Rep; 1999; 6(6):1435-8. PubMed ID: 10523726
[TBL] [Abstract][Full Text] [Related]
12. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.
Noguchi S; Kasugai T; Miki Y; Fukutomi T; Emi M; Nomizu T
Cancer; 1999 May; 85(10):2200-5. PubMed ID: 10326698
[TBL] [Abstract][Full Text] [Related]
14. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
15. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
Serova OM; Mazoyer S; Puget N; Dubois V; Tonin P; Shugart YY; Goldgar D; Narod SA; Lynch HT; Lenoir GM
Am J Hum Genet; 1997 Mar; 60(3):486-95. PubMed ID: 9042907
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.
Chappuis PO; Hamel N; Paradis AJ; Deschênes J; Robidoux A; Potvin C; Cantin J; Tonin P; Ghadirian P; Foulkes WD
Clin Genet; 2001 Jun; 59(6):418-23. PubMed ID: 11453973
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological characteristics of hereditary breast cancer].
Ikeda N; Miyoshi Y; Noguchi S
Nihon Rinsho; 2000 Apr; 58 Suppl():533-6. PubMed ID: 11026045
[No Abstract] [Full Text] [Related]
18. Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients.
Ozdag H; Tez M; Sayek I; Müslümanoglu M; Tarcan O; Içli F; Oztürk M; Ozçelik T
Eur J Cancer; 2000 Oct; 36(16):2076-82. PubMed ID: 11044644
[TBL] [Abstract][Full Text] [Related]
19. [Genetic diagnosis of hereditary breast cancer].
Yano K; Miki Y
Nihon Rinsho; 2000 Apr; 58 Suppl():527-32. PubMed ID: 11026044
[No Abstract] [Full Text] [Related]
20. After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.
Cui J; Antoniou AC; Dite GS; Southey MC; Venter DJ; Easton DF; Giles GG; McCredie MR; Hopper JL
Am J Hum Genet; 2001 Feb; 68(2):420-31. PubMed ID: 11133358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]